Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 5Anxiety Disorders 5Breast Neoplasms 4Pain 3Fatigue 2Depression 2Vulvar Neoplasms 1Vomiting 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Stress, Psychological 1Rectal Neoplasms 1Personal Satisfaction 1Ovarian Neoplasms 1Neoplasms, Second Primary 1Myasthenia Gravis 1Malignant Solid Neoplasm 1Inflammation 1Hematopoietic and Lymphatic System Neoplasm 1Femininity 1Endometrial Neoplasms 1Colonic Neoplasms 1Cancer Pain 1

Interventions

telitacicept 2talquetamab 1bu-zhong-yi-qi-tang 1Walk Test 1Sugammadex 1Robotic Surgical Procedures 1Rituximab 1Psychodrama 1Population Groups 1Plasma Exchange 1Neostigmine 1Mycophenolic Acid 1Muscle Stretching Exercises 1Immunoglobulins, Intravenous 1Immunoglobulins 1Exercise 1Control Groups 1Cognitive Behavioral Therapy 1Art Therapy 1Acupuncture Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Myasthenia Gravis × Art Therapy × Clear all
NCT07125105 2025-08-15

APART-MG

Universite du Littoral Cote d'Opale

Phase NA Not yet recruiting
102 enrolled

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡